Percutaneous radiofrequency treatment for sacroiliac joint pain

ISRCTN ISRCTN45914408
DOI https://doi.org/10.1186/ISRCTN45914408
Secondary identifying numbers NL36871.078.11
Submission date
07/07/2013
Registration date
15/07/2013
Last edited
25/06/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
In the past, research have appeared about the identification and treatment of sacroiliac (SI) joint pain (low back pain). The SI joint has been shown to be involved in 10% to 38% of the patients with chronic low back pain. For identifying SI joint problems, an injection into the joint is still being used. One of the most promising treatments is the use of radio frequency (RF) current (electricity). Several studies describe a good success rate with this kind of treatment. This study aims to find out the value of percutaneous radiofrequency heat lesion (application of heat produced by electric current through the skin) and to find out if a significant and long lasting pain reduction can be obtained as compared to when RF heat lesion was not given. In addition to the above, a cost of an individual treatment as well as cost to the complete healthcare system will be analyzed. The results will be used for further studies.

Who can participate?
Patients aged 18 or more with low back pain can participate in the study.

What does the study involve?
Patients will be randomly allocated to one of two groups. One group receives RF heat lesion treatment and the other group (control)receives treatment procedure that does not have RF heat lesion treatment. After three months, control group patients will receive RF heat lesion treatment. These results are compared separately.

What are the possible benefits and risks of participating?
This procedure is associated with a very small incidence of minor complications. No major complications were found in this procedure.

Where is the study run from?
This study is run from Lievensberg Hospital, Bergen op Zoom, The Netherlands and Franciscus Hospital, Roosendaal, The Netherlands.

When is the study starting and how long is it expected to run for?
The study started in March 2012 and is expected to run until March 2015.

Who is funding the study?
Centre for Pain Medicine, Erasmus University MC, Rotterdam, The Netherlands.

Who is the main contact?
Dr C.W.J. van Tilburg
vtilburg@ziggo.nl

Contact information

Dr Cornelis Wilhelmus Jacobus van Tilburg
Scientific

Multidisciplinary pain centre
Lievensberg hospital
Boerhaaveplein 1
Bergen op Zoom
4624 VT
Netherlands

Study information

Study designRandomised sham-controlled double-blind multicenter clinical trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleRandomised sham-controlled double-blind multicenter clinical trial to evaluate the percutaneous radiofrequency treatment of sacroiliac joint pain
Study acronymRF SIJ
Study objectivesInvestigate the value of percutaneous radiofrequency heat lesion, applied to dorsal ramus of L5 and lateral branches of S1, S2, S3 and S4 nerve roots, more specifically, it tries to determine if a significant and long lasting pain reduction can be obtained as compared to a sham-operated group. In addition to the above a cost analysis will be performed for each
individual treatment as well as for the complete healthcare system. The results will be used for further studies concerning intervention in spine related pain disorders.
Ethics approval(s)Ethics approval has been granted by the Medical Ethics Committee (Medisch Ethische Toetsings Commissie) (METC) Erasmus MC, Rotterdam, The Netherlands on february 7, 2012 (multicenter approval on july 10, 2012), reference number MEC-2011-244.
Health condition(s) or problem(s) studiedSpine-related pain disorders
InterventionPatients with chronic low back pain in whom anamnesis, physical investigation and additional investigations point towards a sacroiliac (SI) joint problem first receive a diagnostic SI joint block:

Sacroiliac joint diagnostic injection:
The diagnostic injection is performed fluoroscopically and by means of one Sluijter-Mehta Kit (SMK) needle (Cotop® via Neurotherm®, Wilmington, Massachusetts, United States) with an overall length of 10 cm. Local anesthesia with 1 mL lidocaine 2% is given for skin infiltration. Correct needle position is confirmed with contrast agent (iohexol (Omnipaque®) 240 mg/dL). The SI joint is infiltrated with 3 mL lidocaine 2%. The results of the diagnostic injections are rated according to Ostelo et al. (Ostelo, 2008), in which a positive result is obtained with a reduction in NRS of 2 or more on 10. Patients with a reduction in NRS of less than 2 on 10 drop out of the study.

When patients are candidates for the RCT they are randomized in two study groups: Radiofrequency heat lesion of the posterior ramus of L5 and lateral branches of S1, S2, S3 and S4 with the Simplicity© III probe versus sham:
Group 1 (treatment group): skin infiltration with 1 mL lidocaine 2% per level, infiltration of the course of the Simplicity© III needle with 10 mL lidocaine 2%, percutaneous radiofrequency heat lesion (85ºC, each step 1.5 minutes) with the NT2000 lesion generator (Neurotherm®, Wilmington, Massachusetts, United States) at the lateral branches of S1, S2, S3 and S4 nerve roots, percutaneous heat lesion (85ºC for 90 seconds, same laesion generator) of the L5 dorsal root primary ramus.
Group 2 (sham-operated group): same procedure as in treatment group except for radiofrequency heat lesion).
This is followed with graded activity and follow up for both groups.

A crossover is provided for the sham-operated group after three months is no significant pain relief is obtained. The results of the crossover group will be analyzed separately, as well as compared with those who received the actual treatment in the first case.
Intervention typeOther
Primary outcome measurePain reduction [Numerical Rating Scale (NRS)] measured on the day of first consultation, 1, 3, 6 and 12 months after treatment
Secondary outcome measures1. Pain: Chronic Pain Acceptance Questionnaire (CPAQ), Four-Dimensional Symptom Questionnaire (4DSQ), Multidimensional Pain Inventory (MPI-DLV) measured on the day of first consultation, 3 and 12 months after treatment
2. Disability: Oswestry Disability Index (ODI) measured on the day of first consultation, 3 and 12 months after treatment
3. Generic health status: Rand-36 measured on the day of first consultation, 3 and 12 months after treatment
4. Kinesiophobia: Tampa Scale for Kinesiophobia (TSK) measured on the day of first consultation, 3 and 12 months after treatment
5. Coping: Pain Coping Inventory (PCI), Pain Cognition List (PCL-2003) measured on the day of first consultation, 3 and 12 months after treatment
6. Costs of intervention
Overall study start date01/03/2012
Completion date01/03/2015

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants60
Key inclusion criteria1. Age 18 years or older
2. Anamnesis and physical investigation suggestive of SI joint pain
3. Decrease in NRS of 2 or more / 10 on diagnostic SI joint block
Key exclusion criteria1. Presence of red flags: possible fracture (major trauma, minor trauma in elderly or osteoporotic), possible tumor or infection [age >50 or <20, history of cancer, constitutional symptoms (fever, chills, weight loss), recent bacterial infection, intravenous (IV) drug abuse, immunosuppression, pain worsening at night or when supine], possible significant neurological deficit, severe or progressive sensory alteration or weakness, bladder or bowel dysfunction, evidence of neurological deficit (in legs or perineum in the case of low back pain)
2. Lumboradicular syndrome
3. Aspecific low back pain
4. Corpus vertebrae problem
5. Progressive neurological defecits
6. Major psychiatric disorder (according to psychiatrists opinion)
7. Anticoagulation cannot be stopped
8. Active infection
9. Pain in other parts of the body that is more severe
10. Allergies to any medication used in the study
11. Pregnancy
12. Communication (language) difficulties (according to physicians opinion)
Date of first enrolment01/03/2012
Date of final enrolment01/03/2015

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Multidisciplinary pain centre
Bergen op Zoom
4624 VT
Netherlands

Sponsor information

Erasmus University Medical Centre (MC) (Netherlands)
University/education

c/o F.J.P.M. Huygen
Centre for Pain Medicine
's-Gravendijkwal 230
Rotterdam
3015 CE
Netherlands

ROR logo "ROR" https://ror.org/018906e22

Funders

Funder type

University/education

Centre for Pain Medicine, Erasmus University MC, Rotterdam, Netherlands

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/11/2016 25/06/2020 Yes No

Editorial Notes

25/06/2020: Publication reference added.